Home Dompe's investigational biotech molecule receives orphan drug...
 

Keywords :   


Dompe's investigational biotech molecule receives orphan drug...

2015-12-08 10:08:14| Biotech - Topix.net

The Dompe biopharmaceutical company announced today that the Committee for Orphan Medicinal Products of the European Medicines Agency has officially designated recombinant human Nerve Growth Factor - the investigational biotech molecule developed by Dompe based on research by Nobel Laureate Rita Levi Montalcini - as an orphan drug for the treatment of neurotrophic keratitis. NGF is the first neurotrophic factor to be identified and purified, and represents one of the most interesting topics being studied in medicine today and specifically in ophthalmology.

Tags: drug receives biotech molecule

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
26.06VW to invest up to $5bn in Tesla rival Rivian
26.06Strategic use of soybean meal to maximize hog carcass weight during summer
26.06Eastern North Pacific Tropical Weather Outlook
26.06Atlantic Tropical Weather Outlook
26.06Aer Lingus pilots begin industrial action over pay dispute
25.06Water requirements in the summer
25.06New model Is transforming the study of liver abscesses in cattle
25.06Royal Mail buyer to make offer for all staff shares
More »